Only 39 Percent of Beijing Facilities Offered HPV Vaccines in 2024
Health

Only 39 Percent of Beijing Facilities Offered HPV Vaccines in 2024

A new study reveals how facility types, digital queues, and educational classes influence HPV vaccination rates in China.

By Sana Malik
Published:
Email this Article
Only 39 Percent of Beijing Facilities Offered HPV Vaccines in 2024
Photo by Diana Polekhina on Unsplash

Only about two in five medical facilities in Beijing offered human papillomavirus (HPV) vaccination services in 2024, according to an evaluation of 499 clinics across the municipality. The study, published in Human Vaccines & Immunotherapeutics, examined how healthcare infrastructure and service allocation influenced the uptake of the vaccine, which protects against the primary viral cause of cervical cancer.

How Healthcare Facility Types Shaped Vaccine Provision Across Beijing

Led by researchers including Q. Yuan and colleagues, the investigation revealed that 467 out of 1,189 healthcare facilities in Beijing provided HPV vaccination during the 2024 calendar year. Primary healthcare facilities, which include community health service centers and township health centers, accounted for the vast majority of these sites at 79.87 percent of all vaccine providers. However, only 58.65 percent of all primary facilities in the municipality offered the shots.

Secondary and tertiary healthcare facilities showed even lower participation rates at 16.04 percent and 23.97 percent, respectively. The authors noted that primary healthcare clinics handle a heavy routine workload, ranging from childhood immunizations to infectious disease surveillance, which can restrict the resources available for delivering non-national immunization program vaccines like HPV shots to the wider public.

Spatial Distribution and Geographic Clustering of Vaccination Clinics

Using spatial analysis tools, the researchers assessed the geographic arrangement of the 499 surveyed clinics. A nearest-neighbor analysis demonstrated that the 467 clinics offering HPV vaccination were significantly clustered across Beijing, with a nearest ratio of 0.689 and a p-value below 0.001. Kernel density estimation further confirmed that these clinics concentrated heavily within the urban core, closely mirroring the underlying population density of the region.

Hot-spot analysis of staff workloads showed uneven distributions across districts. The urban core and inner suburbs contained significant hotspots for staff administering the vaccine, while the outer suburbs displayed no such clusters. The average daily number of HPV vaccine doses administered per staff member across Beijing stood at six doses, suggesting that overall staff capacity remained far below the theoretical maximum thresholds observed in prior occupational studies.

Targeted Service Strategies Associated With Higher Vaccination Volumes

Through univariate and negative binomial regression models, the researchers identified specific operational measures associated with higher vaccination volumes per clinic. Clinics that utilized electronic queuing systems saw a significantly higher ratio of vaccine doses administered, with an incidence rate ratio of 1.45. Providing offline vaccination health education also correlated with increased administration numbers, yielding an incidence rate ratio of 1.43.

Furthermore, holding parent classes or workshops at least four times a month showed a strong positive association with higher vaccination counts, displaying an incidence rate ratio of 2.93 based on a subset of clinics. Online appointment features, such as setting minimum time intervals and displaying available booking slots, also correlated with higher uptake in univariate analyses.

Study Limitations and Contextual Considerations

The authors acknowledged several limitations in their design, noting that the ecological and cross-sectional nature of the study precludes direct causal inferences at the individual level. Because the work was conducted exclusively in Beijing, the findings may not generalize to rural or less economically developed regions with different digital literacy levels and healthcare access. Additionally, metrics regarding staff hours were self-reported from administrative records, which could introduce minor reporting biases.

Despite these caveats, the findings provide baseline evidence for public health authorities as China integrates HPV vaccination into its broader national immunization framework. The team emphasized that expanding adult vaccination clinics in secondary and tertiary facilities, improving digital queuing infrastructure, and boosting targeted health education could help optimize resource allocation and enhance uptake moving forward.

The research was published in Human vaccines & immunotherapeutics on November 18, 2026.

Fact Checked

This article has been fact checked for accuracy, with information verified against reputable sources. Learn more about us and our editorial process.

Last reviewed on .

Article history

  • Latest version

Cite this page:

Malik, Sana. “Only 39 Percent of Beijing Facilities Offered HPV Vaccines in 2024.” BioScience. BioScience ISSN 2521-5760, 18 November 2026. <https://www.bioscience.com.pk/en/subject/health/assessing-resource-allocation-and-exploring-measures-to-promote-human-papillomavirus-vaccination-in-beijing-china>. Malik, S. (2026, November 18). “Only 39 Percent of Beijing Facilities Offered HPV Vaccines in 2024.” BioScience. ISSN 2521-5760. Retrieved November 18, 2026 from https://www.bioscience.com.pk/en/subject/health/assessing-resource-allocation-and-exploring-measures-to-promote-human-papillomavirus-vaccination-in-beijing-china Malik, Sana. “Only 39 Percent of Beijing Facilities Offered HPV Vaccines in 2024.” BioScience. ISSN 2521-5760. https://www.bioscience.com.pk/en/subject/health/assessing-resource-allocation-and-exploring-measures-to-promote-human-papillomavirus-vaccination-in-beijing-china (accessed November 18, 2026).
End of the article